Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis.

Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis.

OBJECTIVES: The aim of this study was to assess the efficacy of strontium ranelate in improving symptoms in knee OA. METHODS: Symptoms were assessed over 3 years in patients with primary knee OA receiving strontium ranelate 2 g/day (n = 454), 1 g/day (n = 445) or placebo (n = 472) in the Strontium R...

Descripció completa

Dades bibliogràfiques
Autors principals:	Bruyère, O, Reginster, J, Bellamy, N, Chapurlat, R, Richette, P, Cooper, C
Format:	Journal article
Idioma:	English
Publicat:	2014

Ítems similars

Clinically Meaningful Effect of Strontium Ranelate On Knee Osteoarthritis Symptoms
per: Bruyere, O, et al.
Publicat: (2012)

Effects of Strontium Ranelate On Knee Osteoarthritis Pain: A Responder Analysis
per: Reginster, J, et al.
Publicat: (2012)

EFFECT OF STRONTIUM RANELATE ON KNEE PAIN IN OSTEOARTHRITIS: A RESPONDER ANALYSIS
per: Cooper, C, et al.
Publicat: (2013)

Strontium Ranelate Significantly Decreases Radiological Progression Using a New Definition For Radiological Progression In Patients With Primary Knee Osteoarthritis Treated With Strontium Ranelate
per: Bruyere, O, et al.
Publicat: (2013)

STRONTIUM RANELATE INCREASES THE NUMBER OF PATIENTS WITH IMPROVEMENT IN OSTEOARTHRITIS SYMPTOMS COMPARED TO PLACEBO IN THE SEKOIA STUDY
per: Bruyere, O, et al.
Publicat: (2013)

STRUCTURE MODIFYING EFFECTS OF STRONTIUM RANELATE IN KNEE OSTEOARTHRITIS
per: Reginster, J, et al.
Publicat: (2012)

STRONTIUM RANELATE DECREASES THE NUMBER OF RAPID RADIOLOGICAL PROGRESSORS FROM THE FIRST YEAR IN SEKOIA STUDY
per: Chevalier, X, et al.
Publicat: (2014)

Strontium Ranelate in Knee Osteoarthritis Trial (SEKOIA): A Structural and Symptomatic Efficacy.
per: Reginster, J, et al.
Publicat: (2012)

Prevention Of Radiological Progression In Patients With Primary Knee Osteoarthritis With Strontium Ranelate
per: Reginster, J, et al.
Publicat: (2013)

STRONTIUM RANELATE REDUCES THE NUMBER OF RADIOLOGICAL OR RADIOCLINICAL PROGRESSORS IN PATIENTS WITH PRIMARY KNEE OSTEOARTHRITIS
per: Reginster, J, et al.
Publicat: (2012)

STRONTIUM RANELATE PREVENTS RADIOLOGICAL PROGRESSION IN PATIENTS WITH PRIMARY KNEE OSTEOARTHRITIS: A RESPONDERS ANALYSIS
per: Cooper, C, et al.
Publicat: (2013)

STRONTIUM RANELATE PREVENTS SPINE OSTEOARTHRITIS PROGRESSION IN PATIENTS WITH PREVALENT SPINAL OSTEOARTHRITIS
per: O Bruyere, et al.
Publicat: (2007-08-01)

EFFICACY AND SAFETY OF STRONTIUM RANELATE IN THE TREATMENT OF KNEE OSTEOARTHRITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED INTERNATIONAL TRIAL
per: Reginster, J, et al.
Publicat: (2011)

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: Results of a double-blind, randomised placebo-controlled trial
per: Reginster, J, et al.
Publicat: (2012)

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial.
per: Reginster, J, et al.
Publicat: (2013)

Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial.
per: Cooper, C, et al.
Publicat: (2012)

STRONTIUM RANELATE EFFECT ON KNEE OSTEOARTHRITIS PROGRESSION: A MRI ANALYSIS
per: Genant, H, et al.
Publicat: (2013)

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
per: Jean-Yves Reginster, et al.
Publicat: (2014-02-01)

Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial
per: Cyrus Cooper, et al.
Publicat: (2013-12-01)

STRONTIUM RANELATE EFFECT ON KNEE OSTEOARTHRTTIS PROGRESSION
per: Zaim, S, et al.
Publicat: (2013)

PATHOGENESIS OF OSTEOARTHRITIS AND SUBSTANTIATION OF THE USE OF STRONTIUM RANELATE
per: Elena Mikhailovna Zaitseva, et al.
Publicat: (2014-02-01)

STRONTIUM RANELATE: WHAT THE FUTURE HOLDS
per: Cooper, C
Publicat: (2011)

STRONTIUM RANELATE DECREASES VERTEBRAL FRACTURE RISK WHATEVER THE LEVEL OF PRETREATMENT BONE TURNOVER MARKERS
per: J COLLETTE, et al.
Publicat: (2007-08-01)

Prophylactic and Therapeutic Use of Strontium Ranelate Reduces the Progression of Experimental Osteoarthritis
per: Thiago A. Rodrigues, et al.
Publicat: (2018-09-01)

Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review
per: T.A. Rodrigues, et al.
Publicat: (2018-06-01)

STRONTIUM RANELATE AND RISK OF VENOUS THROMBOEMBOLISM (VTE): AN UPDATE OF A RETROSPECTIVE COHORT STUDY IN THE UK GENERAL PRACTICE RESEARCH DATABASE (GPRD)
per: Cooper, C, et al.
Publicat: (2012)

Long treatment with strontium ranelate of womenwith postmenopausal osteoporosis: 10-year results
per: J Y Reginster, et al.
Publicat: (2011-04-01)

Strontium ranelate in the treatment of postmenopausal osteoporosis: results of administration in clinical practice
per: N V Toroptsova, et al.
Publicat: (2008-06-01)

STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
per: Nataliya Vladimirovna Toroptsova
Publicat: (2010-09-01)

Strontium ranelate is a drug to treat osteoarthrosis
per: Oksana Anatolyevna Nikitinskaya
Publicat: (2013-03-01)

STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
per: Nataliya Vladimirovna Toroptsova
Publicat: (2010-09-01)

Changes in structure and symptoms in knee osteoarthritis and prediction of future knee replacement over 8 years.
per: Bruyere, O, et al.
Publicat: (2013)

Strontium ranelate in the treatment of osteoporosis: evidence for its efficacy
per: N V Toroptsova, et al.
Publicat: (2010-02-01)

Bivalos (strontium ranelate) administration experience in postmenopausal osteoporosis
per: I A Skripnikova, et al.
Publicat: (2009-04-01)

IMPACT OF COMPONENTS OF THE METABOLIC SYNDROME ON KNEE OSTEOARTHRITIS PROGRESSION IN THE SEKOIA STUDY
per: Eymard, F, et al.
Publicat: (2014)

Strontium ranelate's dual action: A closer look
per: Russell, R
Publicat: (2006)

Pathogenetic treatment with strontium ranelate in women with postmenopausal osteoporosis
per: Olga Borisovna Yershova
Publicat: (2010-12-01)

EFFICACY AND SAFETY OF STRONTIUM RANELATE IN THE TREATMENT OF MALE OSTEOPOROSIS
per: J M Kaufman, et al.
Publicat: (2012-08-01)

THE PLACE OF STRONTIUM RANELATE IN THE TREATMENT OF PATIENTS WITH OSTEOPOROSIS (RESULTS OF THE MARC PROGRAM)
per: O. A. Nikitinskaya, et al.
Publicat: (2018-09-01)

Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
per: Roberto Cesareo, et al.
Publicat: (2009-12-01)